Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 87532
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.87532
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.87532
Figure 4 Comparison of various conditioning regimens in acute myeloid leukemia.
A: Comparison of leukemia free survival (LFS) and over survival (OS) between intravenous busulfan (12.8 mg/kg) combined with cyclophosphamide (120 mg/kg), melphalan (140 mg/kg), and etoposide; B: Comparison of LFS and OS between busulfan (12.8 mg/kg) plus melphalan (140 mg/kg) and busulfan (12.8 mg/kg) plus cyclophosphamide (120 mg/kg). BU: Busulfan; MEL: Melphalan; Cy: Cyclophosphamide; LFS: Leukemia free survival; OS: Over survival; BUCY: Busulfan and cyclophosphamide; BUMEL: Busulfan and melphalan.
- Citation: Maqbool S, Baloch MF, Khan MAK, Khalid A, Naimat K. Autologous hematopoietic stem cell transplantation conditioning regimens and chimeric antigen receptor T cell therapy in various diseases. World J Transplant 2024; 14(1): 87532
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/87532.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.87532